NCT05739123View on ClinicalTrials.gov

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

RecruitingOBSERVATIONAL

Enrollment

728

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

May 31, 2033

Study Completion Date

May 31, 2033

Conditions

Pregnancy RelatedPregnancy ComplicationsPregnancy, High Risk

Interventions

DRUG

Relugolix-Containing Product

Any relugolix-containing therapy

Trial Locations (1)

28401

RECRUITING

PPD, Wilmington

All Listed Sponsors

lead

Sumitomo Pharma Switzerland GmbH

INDUSTRY